Allmed Solutions Ltd (ALMD) - Net Assets

Latest as of December 2025: ILA28.07 Million ILA ≈ $75.25K USD

Based on the latest financial reports, Allmed Solutions Ltd (ALMD) has net assets worth ILA28.07 Million ILA (≈ $75.25K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA31.54 Million ≈ $84.57K USD) and total liabilities (ILA3.48 Million ≈ $9.32K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ALMD asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets ILA28.07 Million
% of Total Assets 88.98%
Annual Growth Rate 4.1%
5-Year Change -46.34%
10-Year Change -26.51%
Growth Volatility 59.4

Allmed Solutions Ltd - Net Assets Trend (2008–2025)

This chart illustrates how Allmed Solutions Ltd's net assets have evolved over time, based on quarterly financial data. Also explore ALMD total assets for the complete picture of this company's asset base.

Annual Net Assets for Allmed Solutions Ltd (2008–2025)

The table below shows the annual net assets of Allmed Solutions Ltd from 2008 to 2025. For live valuation and market cap data, see Allmed Solutions Ltd (ALMD) total market value.

Year Net Assets Change
2025-12-31 ILA28.07 Million
≈ $75.25K
-33.20%
2024-12-31 ILA42.02 Million
≈ $112.65K
-24.93%
2023-12-31 ILA55.97 Million
≈ $150.06K
+3.73%
2022-12-31 ILA53.96 Million
≈ $144.67K
+3.15%
2021-12-31 ILA52.31 Million
≈ $140.25K
+7.26%
2020-12-31 ILA48.77 Million
≈ $130.76K
-13.80%
2019-12-31 ILA56.58 Million
≈ $151.69K
+72.33%
2018-12-31 ILA32.83 Million
≈ $88.02K
-15.28%
2017-12-31 ILA38.76 Million
≈ $103.91K
+1.48%
2016-12-31 ILA38.19 Million
≈ $102.39K
-15.37%
2015-12-31 ILA45.13 Million
≈ $120.98K
+40.32%
2014-12-31 ILA32.16 Million
≈ $86.22K
+6.41%
2013-12-31 ILA30.22 Million
≈ $81.02K
-55.09%
2012-12-31 ILA67.29 Million
≈ $180.40K
-7.00%
2011-12-31 ILA72.36 Million
≈ $193.98K
+175.25%
2010-12-31 ILA26.29 Million
≈ $70.47K
+142.70%
2009-12-31 ILA10.83 Million
≈ $29.04K
-23.66%
2008-12-31 ILA14.19 Million
≈ $38.04K
--

Equity Component Analysis

This analysis shows how different components contribute to Allmed Solutions Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 23692600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock ILA19.22 Million 76.13%
Other Components ILA256.24 Million 1015.02%
Total Equity ILA25.25 Million 100.00%

Allmed Solutions Ltd Competitors by Market Cap

The table below lists competitors of Allmed Solutions Ltd ranked by their market capitalization.

Company Market Cap
TIMES CHINA HLDGS HD -10
F:T2H
$8.53 Million
IL&FS Transportation Networks Limited
NSE:IL&FSTRANS
$8.54 Million
Energy Development Company Limited
NSE:ENERGYDEV
$8.54 Million
FATFISH GROUP LTD.
F:1JU
$8.54 Million
Oncosil Medical Ltd
AU:OSL
$8.52 Million
Touchwood Entertainment Limited
NSE:TOUCHWOOD
$8.52 Million
Yelooo Integra Datanet Tbk PT
JK:YELO
$8.52 Million
Orestone Mining Corp
V:ORS
$8.51 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Allmed Solutions Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 39,307,000 to 25,245,000, a change of -14,062,000 (-35.8%).
  • Net loss of 14,124,000 reduced equity.
  • Other comprehensive income decreased equity by 12,305,000.
  • Other factors increased equity by 12,367,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ILA-14.12 Million -55.95%
Other Comprehensive Income ILA-12.30 Million -48.74%
Other Changes ILA12.37 Million +48.99%
Total Change ILA- -35.77%

Book Value vs Market Value Analysis

This analysis compares Allmed Solutions Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 13.11x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 4.38x to 13.11x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2011-12-31 ILA7.56 ILA33.10 x
2012-12-31 ILA7.90 ILA33.10 x
2013-12-31 ILA3.05 ILA33.10 x
2014-12-31 ILA1.75 ILA33.10 x
2015-12-31 ILA1.58 ILA33.10 x
2016-12-31 ILA0.85 ILA33.10 x
2017-12-31 ILA0.66 ILA33.10 x
2018-12-31 ILA0.45 ILA33.10 x
2019-12-31 ILA0.72 ILA33.10 x
2020-12-31 ILA0.61 ILA33.10 x
2021-12-31 ILA0.63 ILA33.10 x
2022-12-31 ILA0.64 ILA33.10 x
2023-12-31 ILA0.66 ILA33.10 x
2024-12-31 ILA0.46 ILA33.10 x
2025-12-31 ILA2.52 ILA33.10 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Allmed Solutions Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -55.95%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.25x
  • Recent ROE (-55.95%) is below the historical average (-40.14%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2008 -44.58% 0.00% 0.00x 1.09x ILA-7.74 Million
2009 -35.78% 0.00% 0.00x 1.06x ILA-4.96 Million
2010 -35.72% -1980.80% 0.01x 1.36x ILA-12.02 Million
2011 -19.44% -548.85% 0.03x 1.10x ILA-21.30 Million
2012 -44.27% -1116.04% 0.03x 1.20x ILA-36.52 Million
2013 -165.46% -1063.71% 0.11x 1.44x ILA-53.03 Million
2014 -76.63% -501.30% 0.11x 1.39x ILA-27.86 Million
2015 -46.38% -404.25% 0.09x 1.26x ILA-25.44 Million
2016 -62.62% -325.27% 0.14x 1.37x ILA-27.74 Million
2017 -58.98% -294.42% 0.15x 1.35x ILA-26.52 Million
2018 -61.64% -217.43% 0.22x 1.32x ILA-23.45 Million
2019 38.33% 197.25% 0.17x 1.17x ILA16.25 Million
2020 -17.70% -89.08% 0.17x 1.15x ILA-13.55 Million
2021 5.57% 50.64% 0.10x 1.09x ILA-2.23 Million
2022 -21.73% 0.00% 0.00x 1.12x ILA-16.34 Million
2023 2.66% 0.00% 0.00x 1.11x ILA-3.92 Million
2024 -22.27% 0.00% 0.00x 1.14x ILA-12.68 Million
2025 -55.95% 0.00% 0.00x 1.25x ILA-16.65 Million

Industry Comparison

This section compares Allmed Solutions Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $113,471,667
  • Average return on equity (ROE) among peers: -24.14%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Allmed Solutions Ltd (ALMD) ILA28.07 Million -44.58% 0.12x $8.53 Million
Erika Carmel Ltd (BCUR) $88.06 Million -24.76% 0.42x $4.69 Million
Bio-View Ltd (BIOV) $18.18 Million 11.59% 0.71x $4.83 Million
Brainsway Ltd (BWAY) $57.32 Million -11.27% 0.32x $463.07 Million
Erech Finance Cahalacha Ltd (EFNC) $28.37 Million -88.27% 1.44x $1.74 Million
Epitomee Medical Ltd (EPIT) $39.45 Million -39.02% 0.40x $62.09 Million
Erika Carmel-Tech Ltd (ERKA) $88.06 Million -24.76% 0.42x $5.82 Million
Human Xtensions Ltd (HUMX) $104.53 Million -51.30% 0.15x $2.12 Million
Ilex Medical (ILX) $443.54 Million 27.20% 0.76x $141.31 Million
Pulsenmore Ltd (PULS) $153.73 Million -16.67% 0.09x $22.89 Million

About Allmed Solutions Ltd

TA:ALMD Israel Medical Devices
Market Cap
$8.53 Million
ILA3.18 Billion ILA
Market Cap Rank
#27422 Global
#395 in Israel
Share Price
ILA33.10
Change (1 day)
-2.07%
52-Week Range
ILA28.00 - ILA40.50
All Time High
ILA186.00
About

Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more